Gene · 7025
Papers1,849
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,849
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An NR2F1-dependent retinoic acid network controls retinal specialization in mice and reveals foveal hypoplasia in patients with BBSOAS. | bioRxiv | 2026 | 42818154 | PubTator, text mining | PubMed |
| Single-cell transcriptomic atlas of the human fetal uveal tract reveals heterogeneity in melanocyte populations. | iScience | 2026 | 42765034 | PubTator, text mining | PubMed |
| Repurposing of lansoprazole and nitazoxanide as NR2F2 inhibitors in the gastric cancer cell line GCIY: computational insights and siRNA-mediated in vitro tests. | Front Chem | 2026 | 42712908 | PubTator, text mining | PubMed |
| USP11-mediated deubiquitination regulates the protein stability of NR2F1. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42671899 | PubTator, text mining | PubMed |
| A de novo NR2F1 c.330 C > A variant in Bosch-Boonstra-Schaaf optic atrophy syndrome presenting with early-onset developmental and epileptic encephalopathy. | Mol Biol Rep | 2026 | 42606787 | PubTator, text mining | PubMed |
| Self-supervised representations reveal the genetic architecture of human cortical folding. | bioRxiv | 2026 | 42538962 | PubTator, text mining | PubMed |
| USP15 mutation associated with autism spectrum disorder alters progenitor fate and neuronal maturation in human brain organoids. | Mol Cells | 2026 | 42526765 | PubTator, text mining | PubMed |
| Diagnostic Yield and Clinical Impact of Comprehensive WES/WGS Testing Beyond Common Genetic Causes in Hereditary Optic Atrophy. | Clin Genet | 2026 | 42363686 | PubTator, text mining | PubMed |
| Pediatric hereditary optic neuropathies in the United Arab Emirates. | Ophthalmic Genet | 2026 | 42299460 | PubTator, text mining | PubMed |
| The NR2F1-Related 5q14.3-q21.1 deletion causing periventricular heterotopia with cerebral visual impairment: a longitudinal case report and genotype-phenotype analysis. | Front Genet | 2026 | 42180515 | PubTator, text mining | PubMed |
| HiFiMAP: High-resolution fast identity-by-descent mapping test. | medRxiv | 2026 | 42180323 | PubTator, text mining | PubMed |
| Identification of Cell Subpopulation-Specific Driver Genes Reveals Ideal Candidates for Renal Cell Carcinoma Immunotherapy. | Int J Mol Sci | 2026 | 42074110 | PubTator, text mining | PubMed |
| lncRNA NAS1 Deficiency Drives Cisplatin Resistance via NR2F1-Mediated TGFB1/NF-κB Signaling Axis in NSCLC. | Cancers (Basel) | 2026 | 41976381 | PubTator, text mining | PubMed |
| Orphan nuclear receptors recruit TRIM28 to promote telomeric H3K9me3 for the ALT pathway. | EMBO J | 2026 | 41917261 | PubTator, text mining | PubMed |
| An epigenomic investigation of atrial fibrillation in a matched left and right atrial human cohort. | Clin Epigenetics | 2026 | 41906156 | PubTator, text mining | PubMed |
| A spatiotemporal transcriptomic atlas of porcine (Sus scrofa) female early gonadal development. | Commun Biol | 2026 | 41906042 | PubTator, text mining | PubMed |
| Establishing Area-Specific Brain Organoids Through Transcription Factor-Mediated Patterning. | Biology (Basel) | 2026 | 41892247 | PubTator, text mining | PubMed |
| Generation of BBSOAS patient-specific induced pluripotent stem cell lines harboring six NR2F1 pathogenic variants. | Stem Cell Res | 2026 | 41825301 | PubTator, text mining | PubMed |
| Decoding the Mechanisms of Hepatocellular Carcinoma Cancer Stem Cells and Identifying Potential Therapeutic Strategies Based on Single-cell Omics. | Cancer Genomics Proteomics | 2026 | 41771574 | PubTator, text mining | PubMed |
| HES1 oscillations are required for cell cycle reentry in oestrogen receptor-positive breast cancer cells. | Proc Natl Acad Sci U S A | 2026 | 41770916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7025/papers